Skip to main content
Premium Trial:

Request an Annual Quote

Metabolon, Merck KGaA Form Metabolomics Alliance

NEW YORK — Metabolon has signed a multiyear drug development alliance with Germany's Merck KGaA, the companies said on Monday.

Under the terms of the deal, Metabolon will apply its Precision Metabolomics liquid chromatography-mass spectrometry global metabolomics platform — which identifies pharmacodynamic, efficacy, and response biomarkers and tracks changes in biological pathways — to undisclosed early-stage drug development programs across therapeutic areas at Merck.

Additional terms were not disclosed.

In early 2018, Morrisville, North Carolina-based Metabolon was selected to perform large-scale metabolomic profiling on samples from US veterans as part of the US Department of Veterans Affairs' Million Veteran Program.

The Scan

Less Than Half

An effort to reproduce key findings from high-profile preclinical cancer studies finds less than half could be replicated, according to the Scientist.

Still Some SARS-CoV-2 Sequencing Holes

The Wall Street Journal reports that viral genomic surveillance has improved in the US, though says there are still gaps.

Avoiding Passing Them On

People with known disease-linked genetic variants are turning to in vitro fertilization so as to not pass those variants to their children, the Washington Post says.

PNAS Papers on Long Cell-Free DNA in Maternal Plasma, Genetic Propensity for Voting

In PNAS this week: long, cell-free DNA of maternal and fetal origins identified in maternal plasma, and more.